HS Optimus amends Medicorp acquisition deal, allows unit Ambertree to buy 30% stake

• HS Optimus entered a deed of amendment for its agreed purchase of 7,500 Medicorp shares, a 30% stake, from Lee Rui Ren.
• Amendment allows nominee Ambertree, a wholly owned unit, to acquire the stake.
• Lease condition for six Kilanas shophouse units shifted to a post-closing obligation due within six months.
• Seller committed to minimum dividends of SGD 900,000 in aggregate for 2026-2029, with SGD 300,000 annual minimums subject to proration.
• Pre-SPA dividends will remain as a shareholder loan at 4% interest, repayable only if Medicorp maintains at least SGD 4 million operating funds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HS Optimus Holdings Ltd published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: WK6RSYRAJX5ECHTC) on July 15, 2026, and is solely responsible for the information contained therein.